Does presence of bone metastases portend worsened prognosis in metastatic renal cell carcinoma? Analysis of the REMARCC (Registry of MetAstatic RCC) database.
Aaron Bradshaw(University of California San Diego), Ithaar Derweesh(Rush University Medical Center), Maria Carmen Mir(Fundación Instituto Valenciano de Oncología), Tobias Maurer(Universität Hamburg), Francesco Porpiglia(University of Turin), Ricardo Autorino(Virginia Commonwealth University Medical Center), Andrea Minervini(Azienda Ospedaliero-Universitaria Careggi), Maximilian C. Kriegmair(University Medical Centre Mannheim), José Rubio(Fundación Instituto Valenciano de Oncología), Siska Van Bruwaene(AZ Groeninge), Mireía Musquera(Surgical Specialties (Canada)), Alessandro Antonelli(University of Verona), Nicola Pavan(Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo), E. Rousel(University of California San Diego), Maarten Albersen, Shudong Zhang(Peking University), Margaret Meagher(University of California San Diego), Maria Furlan(University of Brescia), Vital Hevia(Hospital Universitario Ramón y Cajal)
Cited by 1
Related Papers
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|660
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
|Nature Communications|2021|386
Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer
|European Urology|2014|297
Urology practice during the COVID-19 pandemic
|Minerva Urologica e Nefrologica|2020|256